OrsoBio, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2021-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://orsobio.com
Phase 2a Study of Safety, Tolerability, and Efficacy of TLC-2716 in Subjects With Hypertriglyceridemia and NAFLD
Phase 2
Recruiting
- Conditions
- HypertriglyceridemiaNonalcoholic Fatty Liver Disease
- Interventions
- Drug: PlaceboDrug: TLC-2716 Dose 1Drug: TLC-2716 Dose 2
- First Posted Date
- 2024-08-21
- Last Posted Date
- 2025-04-03
- Lead Sponsor
- OrsoBio, Inc
- Target Recruit Count
- 30
- Registration Number
- NCT06564584
- Locations
- 🇲🇽
OrsoBio Research Site, Ciudad de México, Mexico
Phase 1/1b Study of TLC-6740 in Healthy Subjects and Subjects with Obesity, with or Without Diabetes
Phase 1
Recruiting
- Conditions
- Healthy SubjectsObesityType 2 Diabetes
- Interventions
- Drug: TLC-6740 Oral SolutionDrug: TLC-6740 TabletOther: Placebo Oral SolutionOther: Placebo TabletDrug: Drug Metabolizing Enzyme
- First Posted Date
- 2023-04-20
- Last Posted Date
- 2025-02-12
- Lead Sponsor
- OrsoBio, Inc
- Target Recruit Count
- 506
- Registration Number
- NCT05822544
- Locations
- 🇳🇿
OrsoBio Reseach Site, Auckland, New Zealand
🇳🇿OrsoBio Research Site, Christchurch, New Zealand
A Study Evaluating Daily Oral Doses of TLC-3595 in Participants With Insulin Resistance
Phase 2
Active, not recruiting
- Conditions
- Insulin Resistance
- Interventions
- Drug: PlaceboDrug: TLC-3595 Dose 2Drug: TLC-3595 Dose 1
- First Posted Date
- 2022-12-27
- Last Posted Date
- 2024-08-20
- Lead Sponsor
- OrsoBio, Inc
- Target Recruit Count
- 76
- Registration Number
- NCT05665751
- Locations
- 🇳🇿
OrsoBio Reseach Site, Auckland, New Zealand
🇳🇿OrsoBio Research Site, Christchurch, New Zealand
A Study to Evaluate Single and Multiple Doses of TLC-2716 in Healthy Participants
- First Posted Date
- 2022-08-02
- Last Posted Date
- 2024-05-20
- Lead Sponsor
- OrsoBio, Inc
- Target Recruit Count
- 100
- Registration Number
- NCT05483998
- Locations
- 🇳🇿
OrsoBio Research Site, Auckland, New Zealand
© Copyright 2025. All Rights Reserved by MedPath